Mining drug-target and drug-adverse drug reaction databases to identify target-adverse drug reaction relationships

Galletti, Cristiano; Mirela Bota, Patricia; Oliva Miguel, Baldomero; Fernández Fuentes, Narcís

doi:http://dx.doi.org/10.1093/database/baab068

Mining drug-target and drug-adverse drug reaction databases to identify target-adverse drug reaction relationships

License

Citation

Galletti C, Bota PM, Oliva B, Fernandez-Fuentes N. Mining drug-target and drug-adverse drug reaction databases to identify target-adverse drug reaction relationships. Database (Oxford). 2021 Oct 20;2021:baab068. DOI: 10.1093/database/baab068

Abstract

The level of attrition on drug discovery, particularly at advanced stages, is very high due to unexpected adverse drug reactions (ADRs) caused by drug candidates, and thus, being able to predict undesirable responses when modulating certain protein targets would contribute to the development of safer drugs and have important economic implications. On the one hand, there are a number of databases that compile information of drug-target interactions. On the other hand, there are a number of public resources that compile information on drugs and ADR. It is therefore possible to link target and ADRs using drug entities as connecting elements. Here, we present T-ARDIS (Target-Adverse Reaction Database Integrated Search) database, a resource that provides comprehensive information on proteins and associated ADRs. By combining the information from drug-protein and drug-ADR databases, we statistically identify significant associations between proteins and ADRs. Besides describing the relationship between proteins and ADRs, T-ARDIS provides detailed description about proteins along with the drug and adverse reaction information. Currently T-ARDIS contains over 3000 ADR and 248 targets for a total of more 17 000 pairwise interactions. Each entry can be retrieved through multiple search terms including target Uniprot ID, gene name, adverse effect and drug name. Ultimately, the T-ARDIS database has been created in response to the increasing interest in identifying early in the drug development pipeline potentially problematic protein targets whose modulation could result in ADRs. Database URL: http://www.bioinsilico.org/T-ARDIS.